Exosome-based Cell Therapy for Diabetic Foot Ulcers: Present and Prospect

Zhou Yang,Mengling Yang,Shunli Rui,Wei Hao,Xiaohua Wu,Lian Guo,David G Armstrong,Cheng Yang,Wuquan Deng
DOI: https://doi.org/10.1016/j.heliyon.2024.e39251
IF: 3.776
2024-01-01
Heliyon
Abstract:Diabetic foot ulcers (DFUs) represent a serious complication of diabetes with high incidence, requiring intensive treatment, prolonged hospitalization, and high costs. It poses a severe threat to the patient's life, resulting in substantial burdens on patient and healthcare system. However, the therapy of DFUs remains challenging. Therefore, exploring cell-free therapies for DFUs is both critical and urgent. Exosomes, as crucial mediators of intercellular communication, have been demonstrated potentially effective in anti-inflammation, angiogenesis, cell proliferation and migration, and collagen deposition. These functions have been proven beneficial in all stages of diabetic wound healing. This review aims to summarize the role and mechanisms of exosomes from diverse cellular sources in diabetic wound healing research. In addition, we elaborate on the challenges for clinical application, discuss the advantages of membrane vesicles as exosome mimics in wound healing, and present the therapeutic potential of exosomes and their mimetic vesicles for future clinical applications.
What problem does this paper attempt to address?